Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC + Immunosuppressive Agents in Children With Severe Aplastic Anemia
NCT07903649Phase 2Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Feb 2021
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in aplastic anemia, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Feb 2021; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07903649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07903649.